Nelson Discusses 'Pre-Wells' Stage of SEC Investigations
November 6, 2018
PCAOB Reporter
Of Counsel Margaret G. Nelson was quoted in an article in the PCAOB Reporter, “Senior enforcement official: SEC will continue to pursue accountants and auditors,” about how to approach the “pre-Wells” stage of an SEC investigation, the period prior to the time the SEC notifies a person or a firm that it is planning to bring an enforcement action against them.
Nelson said she welcomes the opportunity for a pre-Wells notice meeting with SEC staff, though she acknowledged that she may be at a disadvantage because she doesn’t have access to the entire investigatory record and may not have all the information the SEC has.
(Subscription required.)
Nelson said she welcomes the opportunity for a pre-Wells notice meeting with SEC staff, though she acknowledged that she may be at a disadvantage because she doesn’t have access to the entire investigatory record and may not have all the information the SEC has.
(Subscription required.)
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.